{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:32:32Z","timestamp":1790332352817,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007930","name":"Washington University Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR002346"],"award-info":[{"award-number":["KL2 TR002346"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Integrase strand transfer inhibitors (INSTIs) are associated with weight gain in people with HIV (PWH). Less is known about the risk of other metabolic outcomes such as diabetes mellitus and hyperglycemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>IBM\u00ae MarketScan\u00ae databases for commercially and Medicaid-insured adults were used to identify PWH newly initiating antiretroviral therapy (ART). The primary outcome was a composite of new-onset diabetes mellitus\/hyperglycemia in the 6 months following ART initiation and was identified using International Classification of Disease, Ninth revision, Clinical Modification (ICD-9-CM) and ICD-10-CM diagnosis and procedure codes and Current Procedural Terminology, 4th Edition (CPT-4) codes. To examine the relationship between INSTI use and the composite outcome, we estimated the risk using Cox proportional hazards models with calendar time-specific standardized mortality ratio weights.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 42 382 PWH who initiated ART between 1 July 2007 and 30 June 2018, 22 762 (54%) were treated with INSTI-based regimens. Mean age was 38 years, 74% were male, and 19% were Medicaid insured. PWH on INSTIs were 31% more likely to develop new-onset diabetes mellitus\/hyperglycemia (hazard ratio [HR], 1.31; 95% confidence interval [CI], 1.15\u20131.48]) compared with those who initiated non\u2013INSTI-based regimens. When examined individually, the highest risk was associated with elvitegravir (HR, 1.54; 95% CI, 1.32\u20131.97; P &amp;lt; .001) and the lowest risk with raltegravir (HR, 1.19; 95% CI, 1.03\u20131.37; P = .02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>INSTI use was associated with increased risk of new-onset diabetes mellitus\/hyperglycemia in the 6 months following ART initiation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac355","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T19:14:39Z","timestamp":1651605279000},"page":"2060-2065","source":"Crossref","is-referenced-by-count":73,"title":["Integrase Strand Transfer Inhibitors Are Associated With Incident Diabetes Mellitus in People With Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"75","author":[{"given":"Jane A","family":"O\u2019Halloran","sequence":"first","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sahrmann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Parra-Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T","family":"Vo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"},{"name":"Department of Surgery, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"},{"name":"Department of Surgery, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Powderly","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"issue":"8","key":"2023053018550157800_ciac355-B1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","article-title":"Impact on life expectancy of HIV-1 positive individuals of CD4 + cell count and viral load response to antiretroviral therapy","volume":"28","author":"May","year":"2014","journal-title":"AIDS"},{"issue":"6","key":"2023053018550157800_ciac355-B2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2023053018550157800_ciac355-B3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciz407","article-title":"Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy","volume":"70","author":"Bourgi","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2023053018550157800_ciac355-B4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"2023053018550157800_ciac355-B5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001525","article-title":"Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens","volume":"76","author":"Norwood","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"2023053018550157800_ciac355-B6","doi-asserted-by":"crossref","first-page":"e471-e7","DOI":"10.1093\/cid\/ciaa177","article-title":"Risk factors for weight gain following switch to integrase inhibitor-based antiretroviral therapy","volume":"71","author":"Lake","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2023053018550157800_ciac355-B7","doi-asserted-by":"crossref","first-page":"e2234","DOI":"10.1093\/cid\/ciaa1403","article-title":"Risk of incident diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with HIV in the US and Canada","volume":"73","author":"Rebeiro","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2023053018550157800_ciac355-B8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QAI.0000000000002447","article-title":"Metabolic changes associated with the use of integrase strand transfer inhibitors among virally controlled women","volume":"85","author":"Summers","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2023053018550157800_ciac355-B9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/QAD.0000000000002718","article-title":"Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs","volume":"35","author":"Hsu","year":"2021","journal-title":"AIDS"},{"issue":"11","key":"2023053018550157800_ciac355-B10","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1093\/jac\/dkaa330","article-title":"Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study","volume":"75","author":"Ursenbach","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2023053018550157800_ciac355-B11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/0956462416675107","article-title":"Integrase strand transfer inhibitor-associated diabetes mellitus: a case report","volume":"28","author":"Fong","year":"2017","journal-title":"Int J STD AIDS"},{"issue":"1","key":"2023053018550157800_ciac355-B12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jac\/dkx365","article-title":"Dolutegravir-induced hyperglycaemia in a patient living with HIV","volume":"73","author":"McLaughlin","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2023053018550157800_ciac355-B13","doi-asserted-by":"crossref","first-page":"ofab077","DOI":"10.1093\/ofid\/ofab077","article-title":"Bictegravir-based antiretroviral therapy-associated accelerated hyperglycemia and diabetes mellitus","volume":"8","author":"Nolan","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2023053018550157800_ciac355-B14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"2023053018550157800_ciac355-B15","author":"HCUP Databases"},{"issue":"6","key":"2023053018550157800_ciac355-B16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/euhj.2001.2838","article-title":"A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort","volume":"23","author":"Peeters","year":"2002","journal-title":"Eur Heart J"},{"issue":"8","key":"2023053018550157800_ciac355-B17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pds.3386","article-title":"Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy","volume":"22","author":"Mack","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"17","key":"2023053018550157800_ciac355-B18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMp078038","article-title":"Challenges in using observational studies to evaluate adverse effects of treatment","volume":"356","author":"Hughes","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"2023053018550157800_ciac355-B19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/sim.4780100409","article-title":"Channeling bias in the interpretation of drug effects","volume":"10","author":"Petri","year":"1991","journal-title":"Stat Med"},{"issue":"25","key":"2023053018550157800_ciac355-B20","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"4","key":"2023053018550157800_ciac355-B21","doi-asserted-by":"crossref","first-page":"e25702","DOI":"10.1002\/jia2.25702","article-title":"Weight gain before and after switch from TDF to TAF in a U.S. cohort study","volume":"24","author":"Mallon","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"2023053018550157800_ciac355-B22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000002357","article-title":"Brief report: integrase strand transfer inhibitors are associated with lower risk of incident cardiovascular disease in people living with HIV","volume":"84","author":"O'Halloran","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"2023053018550157800_ciac355-B23","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/dom.14512","article-title":"Validation of obesity-related diagnosis codes in claims data","volume":"23","author":"Suissa","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"a","key":"2023053018550157800_ciac355-B24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12913-016-1636-7","article-title":"Modification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study","volume":"16","author":"Nickel","year":"2016","journal-title":"BMC Health Serv Res"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac355\/44278556\/ciac355.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/12\/2060\/50491119\/ciac355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/12\/2060\/50491119\/ciac355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T18:55:55Z","timestamp":1685472955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/12\/2060\/6581614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,5,6]]},"published-print":{"date-parts":[[2022,12,19]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac355","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,15]]},"published":{"date-parts":[[2022,5,6]]}}}